{"name":"Seattle Project Corporation","slug":"seattle-project-corporation","ticker":"","exchange":"","domain":"","description":"","hq":"","founded":0,"employees":"","ceo":"","sector":"","stockPrice":0,"stockChange":0,"stockChangePercent":0,"marketCap":"","metrics":{"revenue":0,"revenueGrowth":0,"grossMargin":0,"rdSpend":0,"netIncome":0,"cash":0,"dividendYield":0,"peRatio":0,"fiscalYear":"FY2026"},"revenueBreakdown":[],"timeline":[{"date":"2026-07-28","label":"Q2 2026 Earnings","type":"earnings","sentiment":"neutral"},{"date":"2026-10-28","label":"Q3 2026 Earnings","type":"earnings","sentiment":"neutral"},{"date":"2027-01-28","label":"Q4 2027 Earnings","type":"earnings","sentiment":"neutral"},{"date":"2027-04-28","label":"Q1 2027 Earnings","type":"earnings","sentiment":"neutral"},{"date":"2027-07-28","label":"Q2 2027 Earnings","type":"earnings","sentiment":"neutral"},{"date":"2027-10-28","label":"Q3 2027 Earnings","type":"earnings","sentiment":"neutral"}],"diseaseAreas":[{"name":"Oncology","slug":"oncology","revenue":0,"percentOfTotal":0,"drugCount":1,"colorKey":"oncology","drugs":[{"name":"Fluoropyrimidine plus leucovorin","genericName":"Fluoropyrimidine plus leucovorin","slug":"fluoropyrimidine-plus-leucovorin","indication":"Colorectal cancer","status":"phase_2"}]},{"name":"Infectious Disease","slug":"infectious-disease","revenue":0,"percentOfTotal":0,"drugCount":1,"colorKey":"immunology","drugs":[{"name":"GRT-C901","genericName":"GRT-C901","slug":"grt-c901","indication":"Treatment of COVID-19","status":"phase_2"}]}],"pipeline":[{"name":"Fluoropyrimidine plus leucovorin","genericName":"Fluoropyrimidine plus leucovorin","slug":"fluoropyrimidine-plus-leucovorin","phase":"phase_2","mechanism":"Inhibits thymidylate synthase","indications":["Colorectal cancer","Breast cancer","Stomach cancer"],"catalyst":""},{"name":"GRT-C901","genericName":"GRT-C901","slug":"grt-c901","phase":"phase_2","mechanism":"GRT-C901 is a small molecule that targets the SARS-CoV-2 main protease.","indications":["Treatment of COVID-19"],"catalyst":""}],"recentEvents":[],"realNews":[{"url":"https://news.google.com/rss/articles/CBMiXEFVX3lxTFB1N2d4NnYwN0JiU181Tm9vV0dUM1c1NWVMUHNCdlZFVmRSZXpmRFp3TnBQUVJXYnFYV1VlNVBIZXU0TzY4bE5BNTd4NGpIT21aYlZHMy1qSW1HWDFH?oc=5","date":"2026-04-06","type":"pipeline","source":"BioSpace","summary":"Layoff Tracker: BioNTech Will Close Singapore Plant, Affecting 85 Employees - BioSpace","headline":"Layoff Tracker: BioNTech Will Close Singapore Plant, Affecting 85 Employees","sentiment":"neutral"},{"url":"https://news.google.com/rss/articles/CBMiuwFBVV95cUxQUF9CM0RhNTA4NVRlSS1Wb2otMTljUktQMzlVOFFZUUN2NHNMMm05aE9UckFOdWhPeVlVd29IWHFpLWNwTmlZbC1BUUZMM25aVERqUUVIeml1bV9kTFkwZ0MzcDFqUkNYejZMUER6Z0ZkX1F1RHAzc1B0OHV0YW9jei1zY254Rklwd2puc1kzN3VWYlkyVFBJRTd0b3RvY2lVYmtEMVlDWXAta3hoU0JveWlsdmJyZlBBU2Mw?oc=5","date":"2026-03-30","type":"earnings","source":"National Today","summary":"Eupraxia Pharmaceuticals Projected to Post Earnings on Tuesday - National Today","headline":"Eupraxia Pharmaceuticals Projected to Post Earnings on Tuesday","sentiment":"neutral"},{"url":"https://news.google.com/rss/articles/CBMirgFBVV95cUxQakk1Y1QtOUNjOWpULUxDMVFwSTdzX3dtTlR0U0xKUS1RQkJjNDVadG9oYV84cGNoenVOTGxLOXhjV20taVdudTFoRzB5QzBFUDJSV0tpTmx0NlFQQV81ODlVOXpjRTk3MThOdHZVX3BYVUpRaUZOdHR1ejdCZ0QzQjRQVmZubFlIRDFkOC05eXlhUjZHMmw4bFo5X2c5cFJ1VHFicUFiS1dBczJhNXc?oc=5","date":"2026-03-17","type":"pipeline","source":"Asia Society","summary":"Executive Roundtable on Investment and Innovation in Chinese Pharmaceuticals - Asia Society","headline":"Executive Roundtable on Investment and Innovation in Chinese Pharmaceuticals","sentiment":"neutral"},{"url":"https://news.google.com/rss/articles/CBMigwJBVV95cUxPeHhnUWplTFpGUTc5ZFAxQVF1bGc2NlhjSnNKTTNpeDFwalpKQlBlZ1gtdkZUTEpDVUVsU0xjRzBTdVdIRWc3SVR1Wm5ERVpCQl81OF9xUEc3a2o3cS1ZLXIxaDFoMWNhbE1ITHJYV2VGSHBWanJacno3bTk5LXZCYjU4YXFMcWdpZHFWWVQySjJnMmJzV2RMS1FtcEUzcnlVVnVPQXE2QmtrdUl4S0ZnazFUUlZnWEItVTRmWlNucmMwWjI4NDF3Z19iZkRxZ040VkZHVURrYk1hRGQ3Yy1BVHhuSzQ4RzJpaUt3X0Z1eEY1OXpPc1p5ZVdhVm5EZWZyRU5Z?oc=5","date":"2026-02-03","type":"pipeline","source":"businesswire.com","summary":"AGC Biologics Seattle Site Now Certified to Manufacture Biologics for Largest Pharmaceutical Market in South America - businesswire.com","headline":"AGC Biologics Seattle Site Now Certified to Manufacture Biologics for Largest Pharmaceutical Market in South America","sentiment":"neutral"},{"url":"https://news.google.com/rss/articles/CBMiswFBVV95cUxOcHMyNUVqQ1dEUzB3V2tvNzRHYzJsUTFqMGtqVW8zcWVBRGpUNDFGQ2Rud2lfak0zWXVqM1JKSnBjajktOXZ2eFNPUTFKR3IzUHVUNXA1Z05waTRva2FjS1FTM1VqSWRKT3RhbUZRaWxkdzdfOFYyamxGdGNzMWJmM2JtTjcwLVVYV3pTalR6cTZkNHVVeVR3NjlKc050ZTVzTmxtVmhGSmRLU1BmOEdfeTNROA?oc=5","date":"2025-12-04","type":"pipeline","source":"spokanejournal.com","summary":"Manufacturers invest in INW - spokanejournal.com","headline":"Manufacturers invest in INW","sentiment":"neutral"},{"url":"https://news.google.com/rss/articles/CBMimwFBVV95cUxOaUVfNGtwejBLMUVBcUZUVWdqN2tjbGRBVzNiQWVPbWNxVE9yMUZJaUpvX283TVJxcUtJTHZIUWJlcm9qRDBkZ2pzdWtiOTNJZ0U4Z3hvbFAxZEZxWEpHRVRPQ05kci1YelZkdmtPQVFDbWEyRHFDX0t0azNKNGVtTGhxTl9oVml1Q1dTeEwyNm5PNWp6a3ZUNnpSbw?oc=5","date":"2025-09-18","type":"pipeline","source":"BioSpace","summary":"Layoffs From Just 6 Pharmas Could Wipe Out Over 39,000 Jobs - BioSpace","headline":"Layoffs From Just 6 Pharmas Could Wipe Out Over 39,000 Jobs","sentiment":"neutral"},{"url":"https://news.google.com/rss/articles/CBMirAFBVV95cUxOdDZJUVhNSVdlOGpJWERpRG9QVTVodWYzMGtQVGxwb3N5OGFQTmd1RTNVN0pwTjBwSWxMSHM3a1FMQkg0XzRNRW8xX1dDZDhvc1kzb2RaaHJBZkhpZ0toR2tadTgtS2MwRTBMU1FyVVB1bVJFbEZZdlI1UGlWZ3VQV0tFeXBuWjdjTFIxNEhCbXBLaTU1SktISnd5bnBENElKUVQ2MkZzbzQxbzhG?oc=5","date":"2025-09-04","type":"pipeline","source":"The Business Journals","summary":"Long-delayed, $1.5B manufacturing complex by Red Bull and others to start construction at former Philip Morris site - The Business Journals","headline":"Long-delayed, $1.5B manufacturing complex by Red Bull and others to start construction at former Philip Morris site","sentiment":"neutral"},{"url":"https://news.google.com/rss/articles/CBMimAFBVV95cUxOTzhQQzVidkFuNE5fRDlXMlVEQi1Ha3ZyeGV5Y2FGNjFtd3A3RzZHNzh5VVMzazU3T1BWTmpRS2E4aFMtMVNHUWFKWDZfTTljWENxdnRXaVVia0FqLUpOSjBUR3I3VHhuZ3FnLW1oVnFXVnd4Sjg3QTZDc1FLR1puVDVlWVRmT1dxRjFKOGhVU2dCNU43MTFhaQ?oc=5","date":"2025-06-13","type":"pipeline","source":"Manufacturing Dive","summary":"UCB to open $5B US factory - Manufacturing Dive","headline":"UCB to open $5B US factory","sentiment":"neutral"},{"url":"https://news.google.com/rss/articles/CBMivAFBVV95cUxPb3pKT3BxRTlERW1wajJJVVZ1NnJUakptM2daNkczcHpKR2JldEtqSFRmMVZXRXIxclpvb0RhWklTVmlTWG1UZlRrb3Z5cmpYcjlGZnRxZXJueEkyWHdQTlJucnAxSF9JVXhZOWZaQXZfcFN6OS01OWRHWFFaNFpodUtmS1NhalVsUjJPemw1bDJ3YzJuSXRXb1JWdWhDdnlWUU5oTnhNbmZRcXRjZVd0TnhEQzFQZC1JTkdDNg?oc=5","date":"2024-09-17","type":"pipeline","source":"GeekWire","summary":"Seattle startup Arzeda raises $38M to create proteins for food, pharma, and other industries - GeekWire","headline":"Seattle startup Arzeda raises $38M to create proteins for food, pharma, and other industries","sentiment":"neutral"},{"url":"https://news.google.com/rss/articles/CBMikgFBVV95cUxPeDdfRURVX1FfNXNsc3hCY0F4SWg0d2tjWVBWamJndVhibmlUNlNiUHE2R2F5Q3dGSlJxODJqbmhrQmVROHFZbTV2cWNLU0pPMDBBVUVSOV9lVGg4eE5MOTdVR2JBQ3BPaHpDVUVtSEdGSDFEZF9sWGhwakIxdFdCNHRDQXdGTldCalJhdV9NYlJ2dw?oc=5","date":"2024-09-04","type":"earnings","source":"Center for American Progress","summary":"5 Ways Project 2025 Puts Profits Over Patients - Center for American Progress","headline":"5 Ways Project 2025 Puts Profits Over Patients","sentiment":"neutral"},{"url":"https://news.google.com/rss/articles/CBMijAFBVV95cUxNaVdJZFk3WDh4S1FRQkM5alJlX21zcEdqcHN1dHNGSHNSUy1FdE9JbVRaYmtuQkdXbS1odFd2TXN5N1RISmcwWDZsN0pRb1U4RklQVTluNXBCWXE4RG5KeEphdzYwbkhOX2hDT0JrcXowQUR6dTBNaVJ0dS1jNTdwLTJjZmZnU3c5MWQwUQ?oc=5","date":"2024-07-30","type":"regulatory","source":"Construction Dive","summary":"DPR lead sees growing demand for US life sciences projects - Construction Dive","headline":"DPR lead sees growing demand for US life sciences projects","sentiment":"neutral"},{"url":"https://news.google.com/rss/articles/CBMieEFVX3lxTE9vemFpZ3REWEtSQmdRX2dTSWdZZ1dGX2dhVEJJV2NvY2d0VGp2VG9XWXhvWFE3S1ViX2cyYzJzdnZkQndoS21DYWFuOXhJclZ5N2JNa2JvVGpPYlZSNW14NzVhVjBuSl91VjZhQUx1NGUtR05EV2xLcw?oc=5","date":"2024-04-15","type":"pipeline","source":"The New York Times","summary":"Chinese Company Under Congressional Scrutiny Makes Key U.S. Drugs (Published 2024) - The New York Times","headline":"Chinese Company Under Congressional Scrutiny Makes Key U.S. Drugs (Published 2024)","sentiment":"neutral"}],"patents":[],"drugCount":2,"phaseCounts":{"phase_2":2},"enrichmentLevel":0,"visitCount":5,"keyCompetitors":[],"therapeuticFocus":[],"financials":null,"yahoo":null}